Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

EXCHANGE ACT OF 1934

 


 

FORM 10-Q

 


 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number: 0-20853

 


 

ANSYS, Inc.

(exact name of registrant as specified in its charter)

 


 

Delaware   04-3219960

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

275 Technology Drive, Canonsburg, PA   15317
(Address of principal executive offices)   (Zip Code)

 

724-746-3304

(Registrant’s telephone number, including area code)

 


 

Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by a check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).    Yes  x    No  ¨

 

The number of shares of the Registrant’s Common Stock, par value $.01 per share, outstanding as of October 29, 2004 was 31,245,770 shares.

 



Table of Contents

ANSYS, INC. AND SUBSIDIARIES

 

INDEX

 

         Page No.

PART I.

  UNAUDITED FINANCIAL INFORMATION     

Item 1.

  Financial Statements     
    Condensed Consolidated Balance Sheets – September 30, 2004 and December 31, 2003    3
    Condensed Consolidated Statements of Income - Three and Nine Months Ended September 30, 2004 and 2003    4
    Condensed Consolidated Statements of Cash Flows – Nine Months Ended September 30, 2004 and 2003    5
    Notes to Condensed Consolidated Financial Statements    6-12
    Report of Independent Registered Public Accounting Firm    13

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations    14-23

Item 3.

  Quantitative and Qualitative Disclosures Regarding Market Risk    24

Item 4.

  Controls and Procedures    24

PART II.

  OTHER INFORMATION     

Item 1.

  Legal Proceedings    25

Item 2.

  Unregistered Sale of Equity Securities and Use of Proceeds    25

Item 3.

  Defaults Upon Senior Securities    25

Item 4.

  Submission of Matters to a Vote of Security Holders    25

Item 5.

  Other Information    25

Item 6.

  Exhibits    26
    SIGNATURES    27
    EXHIBIT INDEX    28

 

ANSYS, ANSYS Workbench, CFX, and any and all ANSYS, Inc. product and service names are registered trademarks or trademarks of ANSYS, Inc. or its subsidiaries located in the United States or other countries. ICEM CFD is a trademark licensed by ANSYS, Inc. All other product names mentioned are trademarks or registered trademarks of their respective manufacturers.

 

2


Table of Contents

PART I – UNAUDITED FINANCIAL INFORMATION

 

Item 1. Financial Statements:

 

ANSYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share information)

(Unaudited)

 

    

September 30,

2004


    December 31,
2003


 
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 114,280     $ 78,038  

Short-term investments

     9,980       4,976  

Accounts receivable, less allowance for doubtful accounts of $1,805 and $2,110, respectively

     14,716       20,028  

Other current assets

     15,831       16,206  

Deferred income taxes

     3,035       3,311  
    


 


Total current assets

     157,842       122,559  
    


 


Property and equipment, net

     5,827       5,801  

Capitalized software costs, net

     864       959  

Goodwill

     35,265       35,151  

Other intangibles, net

     12,334       14,876  

Deferred tax asset

     747       1,213  
    


 


Total assets

   $ 212,879     $ 180,559  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 774     $ 988  

Accrued bonuses

     5,038       4,439  

Other accrued expenses and liabilities

     9,693       10,184  

Deferred revenue

     38,726       37,874  
    


 


Total current liabilities

     54,231       53,485  
    


 


Stockholders’ equity – Note 2:

                

Preferred stock, $.01 par value; 2,000,000 shares authorized

     —         —    

Common stock, $.01 par value; 50,000,000 shares authorized; 33,169,516 shares issued

     332       332  

Additional paid-in capital

     49,438       44,369  

Less treasury stock, at cost: 1,953,906 and 2,634,976 shares, respectively

     (18,853 )     (22,768 )

Retained earnings

     123,018       100,701  

Accumulated other comprehensive income

     4,713       4,440  
    


 


Total stockholders’ equity

     158,648       127,074  
    


 


Total liabilities and stockholders’ equity

   $ 212,879     $ 180,559  
    


 


 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

3


Table of Contents

ANSYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share data)

(Unaudited)

 

     Three Months Ended

    Nine Months Ended

    

September 30,

2004


  

September 30,

2003


   

September 30,

2004


  

September 30,

2003


          

Revenue:

                            

Software licenses

   $ 16,585    $ 14,053     $ 49,262    $ 40,457

Maintenance and service

     15,733      13,985       46,390      39,824
    

  


 

  

Total revenue

     32,318      28,038       95,652      80,281
    

  


 

  

Cost of sales:

                            

Software licenses

     1,162      1,226       3,678      3,873

Amortization of software and acquired technology

     758      871       2,267      2,302

Maintenance and service

     3,521      3,199       9,649      9,782
    

  


 

  

Total cost of sales

     5,441      5,296       15,594      15,957
    

  


 

  

Gross profit

     26,877      22,742       80,058      64,324

Operating expenses:

                            

Selling and marketing

     5,757      5,646       17,843      17,254

Research and development

     6,611      5,879       19,441      17,609

Amortization

     285      276       857      774

General and administrative

     3,763      3,022       10,808      8,798
    

  


 

  

Total operating expenses

     16,416      14,823       48,949      44,435
    

  


 

  

Operating income

     10,461      7,919       31,109      19,889

Other income (expense)

     415      (808 )     791      498
    

  


 

  

Income before income tax provision

     10,876      7,111       31,900      20,387

Income tax provision

     3,277      1,750       9,584      6,275
    

  


 

  

Net income

   $ 7,599    $ 5,361     $ 22,316    $ 14,112
    

  


 

  

Earnings per share – basic – Note 2:

                            

Basic earnings per share

   $ 0.24    $ 0.18     $ 0.72    $ 0.47

Weighted average shares – basic

     31,075      30,212       30,835      29,728

Earnings per share – diluted – Note 2:

                            

Diluted earnings per share

   $ 0.23    $ 0.17     $ 0.68    $ 0.45

Weighted average shares - diluted

     33,231      32,472       32,895      31,608

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

4


Table of Contents

ANSYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

     Nine Months Ended

 
     September 30,
2004


    September 30,
2003


 

Cash flows from operating activities:

                

Net income

   $ 22,316     $ 14,112  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     5,621       5,239  

Deferred income tax provision

     604       309  

Provision for bad debts

     (19 )     174  

Loss on investment

     —         686  

Changes in operating assets and liabilities:

                

Accounts receivable

     5,285       4,629  

Other current assets

     815       2,967  

Accounts payable, accrued expenses and liabilities

     4,301       (2,201 )

Deferred revenue

     792       2,815  
    


 


Net cash provided by operating activities

     39,715       28,730  
    


 


Cash flows from investing activities:

                

Capital expenditures

     (2,595 )     (1,473 )

Capitalization of internally developed software costs

     (524 )     (550 )

Purchases of short-term investments

     (20,103 )     (20,034 )

Maturities of short-term investments

     15,000       30,000  

Acquisition of CFX, net of cash acquired

     —         (21,747 )

Other acquisition payments

     —         (588 )

Purchase of long-term investment

     —         (200 )
    


 


Net cash used in investing activities

     (8,222 )     (14,592 )
    


 


Cash flows from financing activities:

                

Proceeds from issuance of common stock under Employee Stock Purchase Plan

     485       408  

Proceeds from exercise of stock options

     4,121       6,306  
    


 


Cash provided by financing activities

     4,606       6,714  
    


 


Effect of exchange rate changes on cash and cash equivalents

     143       231  
    


 


Net increase in cash and cash equivalents

     36,242       21,083  

Cash and cash equivalents, beginning of period

     78,038       46,198  
    


 


Cash and cash equivalents, end of period

   $ 114,280     $ 67,281  
    


 


Supplemental disclosures of cash flow information:

                

Cash paid during the period for income taxes

   $ 4,334     $ 3,117  
    


 


 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

5


Table of Contents

ANSYS,